ICN Pharmaceuticals Presents at Healthcare 2001 Conference Hosted by Tucker Anthony Sutro Capital Markets

Apr 03, 2001, 01:00 ET from ICN Pharmaceuticals, Inc.

    COSTA MESA, Calif., April 3 /PRNewswire/ -- ICN Pharmaceuticals, Inc.
 (NYSE:   ICN) announced today that the Company is scheduled to present on
 Wednesday, April 4, 2001 at 2:50 p.m. Pacific Time at the 2001 Healthcare
 Conference sponsored by Tucker Anthony Sutro Capital Markets.  The event will
 be held at the Ritz Carlton Hotel in Laguna Niguel, California.
     To hear an audio webcast of the presentation, you may go to
 www.corporate-ir.net/ireye/ir_site.zhtml?ticker=ICN&script=2100&layout=7.
 
     ICN manufactures, markets and distributes a broad range of prescription
 and non-prescription pharmaceuticals, including anti-infectives, anti-virals,
 and anti-cancer drugs, under the ICN brand name.
     Additional information is also available on the corporate website at
 http://www.icnpharm.com.
 
     THE 'SAFE HARBOR' STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM
 ACT OF 1995.  This press release contains forward-looking statements that
 involve risks and uncertainties including, but not limited to, projections of
 future sales, operating income, subsidiary reorganization, regulatory approval
 processes, operations in countries with unstable economies, the progress of
 FDA reviews, and other risks detailed from time to time in the Company's
 Securities and Exchange Commission filings.
 
 

SOURCE ICN Pharmaceuticals, Inc.
    COSTA MESA, Calif., April 3 /PRNewswire/ -- ICN Pharmaceuticals, Inc.
 (NYSE:   ICN) announced today that the Company is scheduled to present on
 Wednesday, April 4, 2001 at 2:50 p.m. Pacific Time at the 2001 Healthcare
 Conference sponsored by Tucker Anthony Sutro Capital Markets.  The event will
 be held at the Ritz Carlton Hotel in Laguna Niguel, California.
     To hear an audio webcast of the presentation, you may go to
 www.corporate-ir.net/ireye/ir_site.zhtml?ticker=ICN&script=2100&layout=7.
 
     ICN manufactures, markets and distributes a broad range of prescription
 and non-prescription pharmaceuticals, including anti-infectives, anti-virals,
 and anti-cancer drugs, under the ICN brand name.
     Additional information is also available on the corporate website at
 http://www.icnpharm.com.
 
     THE 'SAFE HARBOR' STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM
 ACT OF 1995.  This press release contains forward-looking statements that
 involve risks and uncertainties including, but not limited to, projections of
 future sales, operating income, subsidiary reorganization, regulatory approval
 processes, operations in countries with unstable economies, the progress of
 FDA reviews, and other risks detailed from time to time in the Company's
 Securities and Exchange Commission filings.
 
 SOURCE  ICN Pharmaceuticals, Inc.